TITLE

Rising Expenditure on Drugs

AUTHOR(S)
Hamilton, Roderick R.
PUB. DATE
May 1965
SOURCE
British Medical Journal;5/29/1965, Vol. 1 Issue 5447, p1437
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64058961

 

Related Articles

  • Rx Expenditures Predicted to Surge.  // Chain Drug Review;3/15/2010, Vol. 32 Issue 6, p78 

    The article forecasts the rise in the expenditures for prescription drugs to 457.8 billion dollars by 2019 in the U.S.

  • Projecting future drug expenditures--2010. Hoffman, James M.; Doloresco, Fred; Vermeulen, Lee C.; Shah, Nilay D.; Matusiak, Linda; Hunkler, Robert J.; Schumock, Glen T. // American Journal of Health-System Pharmacy;6/1/2010, Vol. 67 Issue 11, p919 

    Purpose. Drug expenditure trends in 2008 and 2009, projected drug expenditures for 2010, and factors likely to influence drug expenditures are discussed. Summary. Various factors are likely to influence drug expenditures in 2010, including drugs in development, the diffusion of new drugs,...

  • Rising drug prices leave many seniors without medications.  // Nation's Health;Sep2003, Vol. 33 Issue 7, p6 

    Provides information on the report "Out-of-Bounds: Rising Prescription Drug Prices for Seniors." Three factors that are contributing to drug expenditures; Way to keep drug prices from rising; Methods used by name-brand manufacturers to keep generic drugs off the market.

  • Drug Spending Soars. Wechsler, Jill // Pharmaceutical Executive;Apr2006, Vol. 26 Issue 4, p26 

    The article forecasts the increase in prescription drugs' expenditure in 2015 by the economist at the Centers for Medicare and Medical Services in the U.S. Rising disposable income, Medicare Part D drug plan implementation, increasing physician payments and drug price growth are among the...

  • Projecting future drug expenditures--2012. HOFFMAN, JAMES M.; LI, EDWARD; DOLORESCO, FRED; MATUSIAK, LINDA; HUNKLER, ROBERT J.; SHAH, NILAY D.; VERMEULEN, LEE C.; SCHUMOCK, GLEN T. // American Journal of Health-System Pharmacy;3/1/2012, Vol. 69 Issue 5, p405 

    Purpose. Factors likely to influence drug expenditures, drug expenditure trends in 2010 and 2011, and projected drug expenditures for 2012 are discussed. Summary. Data were analyzed to provide drug expenditure trends for total drug expenditures and the hospital and clinic sectors. Data were...

  • Changing Prescribing Patterns and Increasing Prescription Expenditures in Medicaid. Fink, Kenneth S.; Byrns, Patricia J. // Annals of Family Medicine;Sep/Oct2004, Vol. 2 Issue 5, p488 

    Determines the extent to which increasing prescription price and changing prescribing patterns contribute to rising prescription expenditures in Medicaid in North Carolina. Factors influencing drug price increases; Drug costs and medical expenditures; Effects of socioeconomic status and health...

  • Projecting future drug expenditures-2007. Hoffman, James M.; Shah, Nilay D.; Vermeulen, Lee C.; Schumock, Glen T.; Grim, Penny; Hunkler, Robert J.; Hontz, Karrie M. // American Journal of Health-System Pharmacy;2/1/2007, Vol. 64 Issue 3, p298 

    Purpose. Drug expenditure trends in 2005 and 2006, projected drug expenditures for 2007, and factors likely to influence drug costs are discussed. Summary. Various factors are likely to affect drug costs, including drug prices, drugs in development, and generic drugs. In 2005, there was a...

  • News Update.  // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p14 

    Reports developments related to clinical trials in the United States as of September 2000. Approval of several health-related drugs by the Food and Drug Administration; Results of clinical trials on cancer and hypertension treatment; Details on the approval of the orphan drug status to Cell...

  • Three-tier benefit trims payer costs without short-term effects on utilization, clinical outcomes.  // Formulary;Jul2001, Vol. 36 Issue 7, p522 

    Explores the advantages of three-tier drug benefits in Tampa, Florida. Implication for payers drug expenditures; Factors contributed to smaller rise in payer drug costs; Absence of consequences for medication continuation; Recommendations on making a therapeutic equivalent to three-tier drugs.

  • Projecting future drug expenditures--2011. Doloresco, Fred; Fominaya, Cory; Schumock, Glen T.; Vermeulen, Lee C.; Matusiak, Linda; Hunkler, Robert J.; Shah, Nilay D.; Hoffman, James M. // American Journal of Health-System Pharmacy;5/15/2011, Vol. 68 Issue 10, p921 

    Purpose. Drug expenditure trends in 2009 and 2010, projected drug expenditures for 2011, and factors likely to influence drug expenditures are discussed. Summary. Various factors are likely to influence drug expenditures in 2011, including drugs in development, the diffusion of new drugs,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics